Your browser doesn't support javascript.
loading
Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial.
Gerard, Jean-Pierre; Barbet, Nicolas; Schiappa, Renaud; Magné, Nicolas; Martel, Isabelle; Mineur, Laurent; Deberne, Mélanie; Zilli, Thomas; Dhadda, Amandeep; Myint, Arthur Sun.
Affiliation
  • Gerard JP; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France. Electronic address: jean-pierre.gerard@nice.unicancer.fr.
  • Barbet N; Centre oncologie radiothérapie Bayard, Villeurbanne, France.
  • Schiappa R; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
  • Magné N; Institut de Cancérologie de la Loire, Saint Etienne, France.
  • Martel I; Le Centre Régional de Lutte Contre le Cancer Léon Bérard, Lyon, France.
  • Mineur L; Institut Sainte Catherine, Avignon, France.
  • Deberne M; CHU de Lyon, Lyon, France.
  • Zilli T; Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Dhadda A; Queen's Centre for Oncology, Castle Hill Hospital, Hull, UK.
  • Myint AS; Clatterbridge Cancer Centre, Clatterbridge, UK.
Lancet Gastroenterol Hepatol ; 8(4): 356-367, 2023 04.
Article in En | MEDLINE | ID: mdl-36801007
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Brachytherapy / Adenocarcinoma Type of study: Clinical_trials Limits: Humans Language: En Journal: Lancet Gastroenterol Hepatol Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Brachytherapy / Adenocarcinoma Type of study: Clinical_trials Limits: Humans Language: En Journal: Lancet Gastroenterol Hepatol Year: 2023 Type: Article